Onderneming HEXO Corp. Toronto S.E.
Aandelen
NRTH
CA4283043079
Farmaceutische producten
Vakgebied
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Charles Bowman
CEO | Chief Executive Officer | - | 08-02-21 |
Pamela McRae
CTO | Chief Tech/Sci/R&D Officer | - | - |
Richard Redekop
COO | Chief Operating Officer | - | 15-06-22 |
Mona Matta
HRO | Human Resources Officer | - | 01-01-18 |
Jackie Fletcher
PRN | Corporate Officer/Principal | - | 14-12-21 |
Joelle Maurais
LAW | General Counsel | - | 01-04-18 |
Besturend
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Director/Board Member | 51 | 12-07-22 | |
Hélène Fortin
BRD | Director/Board Member | 66 | - |
Mark Attanasio
CHM | Chairman | 47 | 22-02-22 |
Vincent Chiara
BRD | Director/Board Member | - | 04-11-16 |
Roger Savell
BRD | Director/Board Member | - | 12-07-22 |
Robin Godfrey
BRD | Director/Board Member | 51 | 22-02-22 |
William Montour
BRD | Director/Board Member | - | 05-01-22 |
Peter Montour
BRD | Director/Board Member | - | 30-08-21 |
Aandelenklasse
Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
---|---|---|---|---|---|
Aandeel A | 1 | 43 996 355 | 42 034 185 ( 95,54 %) | 0 | 95,54 % |
Bedrijfsgegevens
Sector
Vaira. 1 jan. | Kapi. | |
---|---|---|
+39,75% | 4,17 mld. | |
+148,03% | 2,33 mld. | |
+138,10% | 78,45 mln. |